The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.
about
Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expressionChronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceInhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's diseaseThe IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signalingManganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.White matter damage and systemic inflammation in Parkinson's disease.BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.Novel nanomaterials for clinical neuroscience.Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculatureThe endotoxin-induced neuroinflammation model of Parkinson's disease.BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated miceMicroglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonismAntioxidants as treatment for neurodegenerative disorders.Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Enhanced adult neurogenesis increases brain stiffness: in vivo magnetic resonance elastography in a mouse model of dopamine depletionMelatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's diseaseInvolvement of the Fc gamma receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss.Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's diseasePaeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptorAnimal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's diseaseOxidative stress and microglial cells in Parkinson's diseaseThe effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson's disease.The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsyInflammation as a causative factor in the aetiology of Parkinson's diseaseNeuroinflammation is a key player in Parkinson's disease and a prime target for therapy.A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in C57BL miceSuppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.Death in the substantia nigra: a motor tragedy.Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum
P2860
Q25257546-F01F6F88-DC74-4848-8813-D47FD50868EEQ26748974-8D67B4A1-F733-4689-B0F2-13EA6ED7F4DAQ26773064-8F1FCD41-DF29-46B5-9D99-06E21DB3D402Q28175939-ECC7655D-7A28-44DF-AB78-2C4368FBBDE7Q28480459-698F5C5C-EAF6-4EBA-87E3-061ADEAA0C74Q31109638-1DF1DD1D-8193-46B9-B0BE-D487780129ABQ33781574-63789D06-599C-4E47-BA44-401984A9D58AQ33815568-19333829-205C-4107-9285-5728E658CE7DQ33872463-0FF85684-89F1-4FB2-B061-D9B26B0A4CF2Q34009532-B21804E7-5282-4A75-AB49-BFD6856C6381Q34237258-7B65F3D0-B2E9-48DF-9ACF-850A4A4D57EEQ34557246-FB132D80-9F75-4C1D-91AD-6DC4FBC995FEQ34762041-B3B9D40A-1EB6-47EE-B9CE-A2F816D34AF6Q34835467-7CD4B95F-0791-4DCD-AB76-E6D5167D6698Q34974866-18865D72-3ADB-4BC6-B023-66C27A0A881CQ35025103-2DDF8F04-79EF-46D8-BFA7-3058CE92F8D4Q35068792-0E722EFA-EB46-4953-AB1D-61081A6EC414Q35131303-A13888BD-D348-4436-85B9-02F2DF10F28BQ35165389-753AAF97-22A3-44DF-8EBB-F2B0F92EA66BQ35309412-E26C1493-A4FB-40AE-841E-B3F322062B3CQ35320917-10F428B6-D7CB-4DAE-90F8-97AB7271224BQ35545909-7342A529-E59B-42F6-9C3B-34C933C5EEA2Q35589979-E6BA7802-812F-439F-A5FA-D79660BC7B77Q35799121-6785DCE7-E92E-4DAA-8F13-F9D3C61C0424Q35846770-0272CE95-7E13-4388-9212-160DD99ADD46Q35876266-6B0DCB79-D308-470E-8560-E381469BBD0EQ35881882-BB4EC3A5-DD44-4DE7-BBC0-55C144C8BE5AQ35925804-3CE123C6-8EDE-4B48-8FB4-2100DBCB2917Q35960407-69F3DC6B-482D-4174-9266-B1AF8D566009Q36052641-D47D6770-CA0F-490F-A45C-CAE4E8F7059EQ36085162-6BC08825-8B5F-4E17-A4D1-D65BFC977E67Q36147318-AFE1340B-7614-45EB-A01A-17AE40B223D4Q36157523-AC474FB4-C256-46F0-A0AB-F948F84B947EQ36215480-E15B47F2-DB59-4192-88A8-351CA1339B51Q36373813-8399DE8C-F30F-430E-8CBA-BD3D12C56CE8Q36449229-4B1503F0-614D-4B77-B19C-F2576AFE2FEEQ36607332-96AFCD8E-5615-4CC3-9130-6C121C8B4758Q36822317-150C3500-C3E6-49FC-8EBE-A80B9B29D5E1Q36847262-271DDC0F-0E4B-46CA-BAA7-7A3B9F04A415Q36954618-C6F7AED6-A070-4E41-8DB6-32FEF3412DE9
P2860
The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
The inflammatory reaction foll ...... yridine intoxication in mouse.
@en
The inflammatory reaction foll ...... yridine intoxication in mouse.
@nl
type
label
The inflammatory reaction foll ...... yridine intoxication in mouse.
@en
The inflammatory reaction foll ...... yridine intoxication in mouse.
@nl
prefLabel
The inflammatory reaction foll ...... yridine intoxication in mouse.
@en
The inflammatory reaction foll ...... yridine intoxication in mouse.
@nl
P2093
P356
P1476
The inflammatory reaction foll ...... yridine intoxication in mouse.
@en
P2093
Członkowska A
Członkowski A
Kohutnicka M
Kurkowska-Jastrzebska I
P356
10.1006/EXNR.1998.6993
P407
P577
1999-03-01T00:00:00Z